Headache was mainly present in patients with anti-CTLA-4 and anti-CTLA-4/PD-1 induced hypophysitis (83% and 58% of patients, respectively versus 8% of patients with anti-PD-(L)-1 induced hypophysitis). Here, CTLA4 is linked to hypophysitis.